MEC Plus Full List View

MEC Plus

Major Challenges Treating Myelodysplastic Syndrome
Major Challenges Treating Myelodysplastic Syndrome
Rami Komrokji, MD
CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP
De Novo Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia
Alexis M. Cruz Chacon, MD
De Novo Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia
Alexis M. Cruz Chacon, MD
New Approaches for Follicular Lymphoma
New Approaches for Follicular Lymphoma
Nakhle S. Saba, MD
DLBCL & Hodgkin’s Disease: Novel Approaches
DLBCL & Hodgkin’s Disease: Novel Approaches
Eduardo Sotomayor, MD
T-Cell NHL: Novel Approaches & Challenges
T-Cell NHL: Novel Approaches & Challenges
Steven Rosen, MD
RET, MET & NTRK Mutations in NSCLC
RET, MET & NTRK Mutations in NSCLC
Mark Socinski, MD
ALK, ROS1 & BRAF Mutations in NSCLC
ALK, ROS1 & BRAF Mutations in NSCLC
Jonathan Riess, MD, MS
EGFR, K-RAS and ERBB2 Mutations in NSCLC
EGFR, K-RAS and ERBB2 Mutations in NSCLC
Edgardo S. Santos Castillero, MD, FACP
EGFR, K-RAS and ERBB2 Mutations in NSCLC
EGFR, K-RAS and ERBB2 Mutations in NSCLC
Edgardo S. Santos Castillero, MD, FACP
Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?
Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?
Luis E. Raez, MD